CRSP

Q: What is the price of CRISPR Therapeutics (CRSP) today?

The price of CRISPR Therapeutics (CRSP) today is $ 52.17, with return of 1.95% compared to the last year. The price of CRISPR Therapeutics (CRSP) started the year trading around $ 39.36 and today it is at $ 52.17. Follow the real-time price chart, the historical price of CRISPR Therapeutics (CRSP) and international markets.

Q: When does CRISPR Therapeutics (CRSP) pay dividends?

CRISPR Therapeutics (CRSP) did not distribute dividends in the last year.

Q: Is CRISPR Therapeutics (CRSP) worth it?

Currently, CRISPR Therapeutics (CRSP) is priced at $ 52.17, with a P/E of -9.96%, representando um desvio de -823% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 1.95 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 1.95%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy CRISPR Therapeutics (CRSP) stock?

Investing in stocks of CRISPR Therapeutics (CRSP) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of CRISPR Therapeutics (CRSP) yield today?

The yield of CRISPR Therapeutics (CRSP) was -18.47% in the last month, 1.95% in the last year and -62.86% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of CRISPR Therapeutics (CRSP) today, the total investment would be $ 5,217.00, based on the current price of $ 52.17.If past performance were to repeat, the return on your investment would be:In 1 year: $ 5,318.73In 5 years: $ 1,937.59In 10 years: $ 5,217.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

CRISPR Therapeutics AG

Price

$ 52.17

return (12m)

1.95%

p/e

-9.96

p/bv

2.54

DIVIDEND YIELD

0.00%

price CRSP

CRSP

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of CRSP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-18.47%

3 months

-0.93%

1 year

1.95%

2 years

-27.05%

5 years

-62.86%

10 years

0.00%

Fundamentals CRSP

review the fundamentals of CRISPR Therapeutics shares

P/E

-9.96

Sector: -3.62 Industry: -3.62

P/SALES RATIO (PSR)

139.02

Sector: -3.30 Industry: -3.30

P/BV

2.54

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-21.75%

Sector: -63.21% Industry: -63.21%

ROE

-25.49%

Sector: -66.02% Industry: -66.02%

ROIC

-162.04%

Sector: -1,132.68% Industry: -1,132.68%

NET MARGIN

-100.00%

Sector: -41.11% Industry: -41.11%

GROSS MARGIN

-100.00%

Sector: 39.13% Industry: 39.13%

OPERATING MARGIN

-100.00%

Sector: -40.99% Industry: -40.99%

P/EBITDA

-8.76

Sector: -3.65 Industry: -3.65

P/EBIT

-8.47

Sector: -3.76 Industry: -3.76

P/ASSET

2.17

Sector: 1.47 Industry: 1.47

BVPS

21.05

Sector: 1.76 Industry: 1.76

EPS

-5.37

Sector: -2.04 Industry: -2.04

EQUITY RATIO

0.85

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

117.50%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

6.96%

Sector: - Industry: -

Fundamentals CRSP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.71	0.00	0.00%	2.47%	$ 495.09 B	27.26%
PFE	14.63	1.54	10.56%	8.46%	$ 143.80 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	14.23	8.21	57.70%	3.42%	$ 219.31 B	32.78%
MRK	13.76	0.00	0.00%	3.09%	$ 261.87 B	29.63%
AZN	30.60	6.26	20.45%	1.69%	$ 287.62 B	16.17%
BMY	16.59	5.39	32.47%	5.04%	$ 100.17 B	12.57%
GILD	19.29	7.29	37.80%	2.50%	$ 156.42 B	27.88%
ZTS	21.42	10.52	49.11%	1.51%	$ 56.78 B	28.21%
HALO	14.03	16.58	118.17%	0.00%	$ 8.35 B	47.91%
REGN	17.72	2.62	14.79%	0.34%	$ 81.14 B	32.13%
AMGN	26.53	19.32	72.82%	2.72%	$ 185.86 B	19.47%
VRTX	30.20	6.41	21.22%	0.00%	$ 111.00 B	31.35%
MCK	27.09	-189.03	-697.75%	0.33%	$ 109.26 B	1.04%
ADMA	21.89	10.63	48.57%	0.00%	$ 4.58 B	42.87%
CAH	31.67	-18.50	-58.40%	0.96%	$ 50.52 B	0.68%
BIIB	16.64	1.47	8.83%	0.00%	$ 26.77 B	15.98%
HRMY	11.02	2.45	22.24%	0.00%	$ 2.05 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

CRSP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY CRISPR Therapeutics

CRISPR Therapeutics AG

Average user rating I10

4.0 (10 people)

United States

12 years

Founded: 2013

2016

Time since IPO - 9 years

93

Employees

The Company CRISPR Therapeutics AG (United States), is listed on Nasdaq with a market cap of $ 4.87 Billions, having an equity of $ 1.92 Billion.

With a total of 93 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 35.00 Millions, which generated a loss in the amount of $ -488.30 Millions.

As for its main indicators, the Company has a P/E ratio of -9.96, a P/BV ratio of 2.54 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker CRSP.

Market cap

$ 4.87 Billions

Equity

$ 1.92 Billion

US$ 1,915,980,000.00

Assets

$ 2.25 Billions

US$ 2,245,310,000.00

Total Shares Outstanding

91.00 Millions

91,000,000

Average Daily Trading Volume

$ 2.62 Millions

US$ 2,617,547.06

Sector

Health Care

Industry

Biotechnology

CRSP

CRSP revenue and profits

Financial Results CRSP

DRAG THE FRAME TO SEE MORE DATA

CRSP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 856.89 38,66% (12M)

P/E

27.09

0.33%

ROE

-697.75%

P/BV

-189.03

CAH - Cardinal Health

$ 208.00 72,69% (12M)

P/E

31.67

0.96%

ROE

-58.40%

P/BV

-18.50

JNJ - Johnson & Johnson

$ 205.34 37,82% (12M)

P/E

19.71

2.47%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 101.83 5,82% (12M)

P/E

13.76

3.09%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.27 6,02% (12M)

P/E

14.63

8.46%

ROE

10.56%

P/BV

1.54

ABBV - AbbVie

$ 225.11 29,16% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 90.52 37,90% (12M)

P/E

30.60

1.69%

ROE

20.45%

P/BV

6.26

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 856.89 38,66% (12 M)

P/L

27.09

0.33%

ROE

-697.75%

P/VP

-189.03

CAH - Cardinal Health

$ 208.00 72,69% (12 M)

P/L

31.67

0.96%

ROE

-58.40%

P/VP

-18.50

JNJ - Johnson & Johnson

$ 205.34 37,82% (12 M)

P/L

19.71

2.47%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 101.83 5,82% (12 M)

P/L

13.76

3.09%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.27 6,02% (12 M)

P/L

14.63

8.46%

ROE

10.56%

P/VP

1.54

ABBV - AbbVie

$ 225.11 29,16% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 90.52 37,90% (12 M)

P/L

30.60

1.69%

ROE

20.45%

P/VP

6.26

Frequently Asked Questions

What is the price of CRISPR Therapeutics (CRSP) today?

The price of CRISPR Therapeutics (CRSP) today is $ 52.17, with return of 1.95% compared to the last year. The price of CRISPR Therapeutics (CRSP) started the year trading around $ 39.36 and today it is at $ 52.17. Follow the real-time price chart, the historical price of CRISPR Therapeutics (CRSP) and international markets.

When does CRISPR Therapeutics (CRSP) pay dividends?

CRISPR Therapeutics (CRSP) did not distribute dividends in the last year.

Is CRISPR Therapeutics (CRSP) worth it?

Currently, CRISPR Therapeutics (CRSP) is priced at $ 52.17, with a P/E of -9.96%, representando um desvio de -823% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 1.95 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 1.95%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy CRISPR Therapeutics (CRSP) stock?

Investing in stocks of CRISPR Therapeutics (CRSP) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of CRISPR Therapeutics (CRSP) yield today?

The yield of CRISPR Therapeutics (CRSP) was -18.47% in the last month, 1.95% in the last year and -62.86% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of CRISPR Therapeutics (CRSP) today, the total investment would be $ 5,217.00, based on the current price of $ 52.17.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 5,318.73
In 5 years: $ 1,937.59
In 10 years: $ 5,217.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

CRSP

CRISPR Therapeutics AG

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of CRSP

review the fundamentals of CRISPR Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY CRISPR Therapeutics

CRISPR Therapeutics AG

United States

12 years

2016

93

PROFIT X PRICE CRSP

Financial Results CRSP

CRSP cash flow

asset growth - CRSP

CRSP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions